✦ LIBER ✦

PDB32 ECONOMIC AND HEALTH CONSEQUENCES OF THE USE OF A DPP4 PLUS METPHORMINE SCHEME IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES IN MEXICO FROM THE PRIVATE PERSPECTIVE

✍ Scribed by P Anaya; A Juarez-Garcia; J Vargas-Valencia; R Uc-Coyoc; BM Donato; S Islas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Direct Costs of Type 2 Diabetes in Mexic

✍ Chatzitheofilou, I.; Babineaux, S.M.; Ramírez-Gámez, J.; McDonell, A.; Vega-Hern 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PDB17 Comparison of Clinical and Economi

✍ Bron, M.; Chen, K.; Cheng, D.; Bensimon, A.G.; Wu, E.Q. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Economic Evaluation of Insulin Lispro Mi

✍ Carlos, F.; Ramírez-Gámez, J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PDB17 THE HEALTH CARE COSTS OF LONG-ACTI

✍ J Gundgaard; T Christensen; TL Thomsen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCV32 COST-EFFECTIVENESS OF IRBESARTAN I

✍ H Hernandez; L Lepe; A Gonzalez; A Lemus 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

The Use of Premixed Insulin Analogues in

✍ Ali A. Rizvi; Robert J. Ligthelm 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 989 KB